San Francisco, CA · Founded 2024 · Privately Held (backing)
Operator of biopharmaceutical development services intended for translational research and global licensing purposes. Expedition Therapeutics is based in San Francisco, CA and was founded in 2024. It was valued at $1 billion at its Series B in Aug 2026, the last priced event on record. It has raised $165 million across 1 recorded round; the latest was an $115 million Series B in Aug 2026.
PMV mark · valuation
$1.0B
Oct 2026
Priced at
its Series B
Aug 2026
Total raised
$165.0M
Last round
Series B
Aug 2026
Cap table — not yet on record
Expedition Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Expedition Therapeutics with a free account
·The post-money valuation on its round
·The complete investor list: 14 names
·Watch Expedition Therapeutics: the Monday email on marks, rounds and moves
Where does Expedition Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Expedition Therapeutics's 1 recorded funding rounds.
